Read the latest RCOphth news updates and guidance here.
Letters have been sent recently to NHS organisations across England and the devolved administrations encouraging them to continue to look favourably on requests from doctors seeking their support to undertake national or regional work for the wider benefit of the public, and of health services.
To support the College’s work to address the challenges to long term sustainable patient care created by the growing role of independent sector providers, we are inviting members to join working groups on the cataract referral process and the postoperative pathway.
This draft guideline and its supporting evidence are now out for consultation. It is a valuable opportunity to ensure that the guideline considers issues important to you and your patients. The consultation page has all the information and documents you need to comment.
The Royal College of Ophthalmologists (RCOphth) has produced a new draft clinical guideline on the management of Angle-Closure Glaucoma. This has been developed through a guideline development group (GDG) chaired by Professor Paul Foster. The College would now welcome any comments or observations on the content, format, or recommendations in this new guidance, to help contribute to and influence the final guideline.
As Chair, you will provide leadership of the Clinical Leads Forum supporting ophthalmic clinical leads in their roles. This is a great role for someone who wants to make an impact on eye care services and support fellow leads in delivering the best services possible.
We’ve updated our Ophthalmic Service Guidance for paediatric ophthalmology! Our 2021 guidance represents the expert consensus, based on available evidence and national guidance, of the Paediatric Sub-committee of The Royal College of Ophthalmologists (RCOphth).
The College has been made aware that the manufacturers of Visudyne (verteporfin) are experiencing significant production delays and new stocks of Visudyne will not be available for the UK market until early 2022. Due to the low volume of circulating stock of Visudyne in the UK the Department of Health and Social Care has made the decision to divert the remaining stock to the national ophthalmic oncology centres.
In this episode, we speak with Quresh Mohamed, a Consultant Ophthalmologist from Cheltenham. We discuss his paper entitled, ‘Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity'.
The Royal College of Ophthalmologists (RCOphth) and The College of Optometrists are issuing interim recommendations on routine cataract care to help rapidly increase hospital capacity to see patients with urgent, complex or sight threatening disease.
In this episode we speak with Alessandro Rabiolo, a glaucoma Fellow at Moorfields Eye Hospital about his recent paper, 'Hypotony-associated Complications after Deep Sclerectomy: Incidence, Risk Factors, and Long-Term Outcomes’.
